| David Shved, DO | |
|
975 E 3rd St, Chattanooga, TN 37403 | |
| (423) 778-5179 | |
| (423) 778-2108 |
| Full Name | David Shved |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 8 Years |
| Location | 975 E 3rd St, Chattanooga, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003262593 | NPI | - | NPPES |
| 1003262593 | Other | FL | OTHER |
| 3706 | Other | TN | MEDICAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 3706 (Tennessee) | Secondary |
| 208M00000X | Hospitalist | 3706 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Erlanger Medical Center | Chattanooga, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Chattanooga Hamilton County Hospital Authority | 0547179731 | 156 |
| Erlanger Health | 1153780226 | 352 |
News Archive
Regeneron Pharmaceuticals, Inc. announced financial and operating results for the first quarter of 2010. The Company reported a net loss of $30.5 million, or $0.38 per share (basic and diluted), for the first quarter of 2010 compared with a net loss of $15.4 million, or $0.19 per share (basic and diluted), for the first quarter of 2009.
High physical fitness is known to be related to enhanced blood vessel dilation and blood flow (endothelial function) in aging men.
Food and Drug Administration (FDA) is currently reviewing the combination of extended release (ER) niacin and laropiprant under the trademark Cordaptive (ER niacin/laropiprant). The CHMP recommendation does not apply to regulatory decisions by the FDA and no inferences should be made about pending FDA regulatory actions based on the recommendation of the CHMP.
Cell sorting plays a fundamental role in molecular biology, pathology, immunology and virology research. It requires the ability to rapidly search through and sort out cells based on their unique chemical features and shapes.
› Verified 9 days ago
| Entity Name | Saint Thomas Medical Partners |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437194669 PECOS PAC ID: 1557269354 Enrollment ID: O20031230000470 |
News Archive
Regeneron Pharmaceuticals, Inc. announced financial and operating results for the first quarter of 2010. The Company reported a net loss of $30.5 million, or $0.38 per share (basic and diluted), for the first quarter of 2010 compared with a net loss of $15.4 million, or $0.19 per share (basic and diluted), for the first quarter of 2009.
High physical fitness is known to be related to enhanced blood vessel dilation and blood flow (endothelial function) in aging men.
Food and Drug Administration (FDA) is currently reviewing the combination of extended release (ER) niacin and laropiprant under the trademark Cordaptive (ER niacin/laropiprant). The CHMP recommendation does not apply to regulatory decisions by the FDA and no inferences should be made about pending FDA regulatory actions based on the recommendation of the CHMP.
Cell sorting plays a fundamental role in molecular biology, pathology, immunology and virology research. It requires the ability to rapidly search through and sort out cells based on their unique chemical features and shapes.
› Verified 9 days ago
| Entity Name | Chattanooga Hamilton County Hospital Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154751931 PECOS PAC ID: 0547179731 Enrollment ID: O20040302001086 |
News Archive
Regeneron Pharmaceuticals, Inc. announced financial and operating results for the first quarter of 2010. The Company reported a net loss of $30.5 million, or $0.38 per share (basic and diluted), for the first quarter of 2010 compared with a net loss of $15.4 million, or $0.19 per share (basic and diluted), for the first quarter of 2009.
High physical fitness is known to be related to enhanced blood vessel dilation and blood flow (endothelial function) in aging men.
Food and Drug Administration (FDA) is currently reviewing the combination of extended release (ER) niacin and laropiprant under the trademark Cordaptive (ER niacin/laropiprant). The CHMP recommendation does not apply to regulatory decisions by the FDA and no inferences should be made about pending FDA regulatory actions based on the recommendation of the CHMP.
Cell sorting plays a fundamental role in molecular biology, pathology, immunology and virology research. It requires the ability to rapidly search through and sort out cells based on their unique chemical features and shapes.
› Verified 9 days ago
| Entity Name | Erlanger Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477256303 PECOS PAC ID: 1153780226 Enrollment ID: O20230707000849 |
News Archive
Regeneron Pharmaceuticals, Inc. announced financial and operating results for the first quarter of 2010. The Company reported a net loss of $30.5 million, or $0.38 per share (basic and diluted), for the first quarter of 2010 compared with a net loss of $15.4 million, or $0.19 per share (basic and diluted), for the first quarter of 2009.
High physical fitness is known to be related to enhanced blood vessel dilation and blood flow (endothelial function) in aging men.
Food and Drug Administration (FDA) is currently reviewing the combination of extended release (ER) niacin and laropiprant under the trademark Cordaptive (ER niacin/laropiprant). The CHMP recommendation does not apply to regulatory decisions by the FDA and no inferences should be made about pending FDA regulatory actions based on the recommendation of the CHMP.
Cell sorting plays a fundamental role in molecular biology, pathology, immunology and virology research. It requires the ability to rapidly search through and sort out cells based on their unique chemical features and shapes.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Shved, DO 975 E 3rd St # 159, Chattanooga, TN 37403-2147 Ph: (423) 778-5179 | David Shved, DO 975 E 3rd St, Chattanooga, TN 37403 Ph: (423) 778-5179 |
News Archive
Regeneron Pharmaceuticals, Inc. announced financial and operating results for the first quarter of 2010. The Company reported a net loss of $30.5 million, or $0.38 per share (basic and diluted), for the first quarter of 2010 compared with a net loss of $15.4 million, or $0.19 per share (basic and diluted), for the first quarter of 2009.
High physical fitness is known to be related to enhanced blood vessel dilation and blood flow (endothelial function) in aging men.
Food and Drug Administration (FDA) is currently reviewing the combination of extended release (ER) niacin and laropiprant under the trademark Cordaptive (ER niacin/laropiprant). The CHMP recommendation does not apply to regulatory decisions by the FDA and no inferences should be made about pending FDA regulatory actions based on the recommendation of the CHMP.
Cell sorting plays a fundamental role in molecular biology, pathology, immunology and virology research. It requires the ability to rapidly search through and sort out cells based on their unique chemical features and shapes.
› Verified 9 days ago
Bradley Rayford Keel, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1067 Riverfront Pkwy Ste 201, Chattanooga, TN 37402 Phone: 423-954-7177 Fax: 423-560-7177 | |
Froilan Borja Joves, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2525 De Sales Avenue, Chattanooga, TN 37404 Phone: 423-495-2620 Fax: 423-495-2625 | |
Mr. Jerry Lynn Reed Jr., APRN, FNP-C Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 7480 Ziegler Rd Ste 150, Chattanooga, TN 37421 Phone: 423-933-2001 Fax: 281-816-3417 | |
Dr. Sachin H. Amin, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 975 E 3rd St, Attn: University Hospitalists Department, Chattanooga, TN 37403 Phone: 423-661-7718 Fax: 423-778-2108 | |
Antoinette Boameh, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 941 Spring Creek Rd, Chattanooga, TN 37412 Phone: 423-855-3691 | |
Mrs. Laura Bond Youngblood, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 960 E. Third Street, Suite #208, Chcha Dba University Medical Associates, Chattanooga, TN 37403 Phone: 423-778-2550 Fax: 423-778-4452 | |
Dr. Adrien K Strickland, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 605 Glenwood Dr, Suite 404, Chattanooga, TN 37404 Phone: 423-629-7220 Fax: 423-629-4091 |